Related Experiment Video
Updated: Jul 10, 2026
06:55
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Accounting for variability in individual hierarchical clinical trial data
Fabián Tibaldi1, Didier Renard, Geert Molenberghs
1GlaxoSmithKline Biologicals, Rixensart, Belgium. fabian.tibaldi@skynet.be
Pharmaceutical Statistics
|October 20, 2007
Summary
This study extends meta-analysis to hierarchical data by incorporating parameter variances into mixed models. This statistical approach enhances medical data analysis for broader applications.
Area of Science:
- Biostatistics
- Medical Informatics
- Clinical Trials
Background:
- Meta-analytical methods are standard for analyzing aggregated medical data from independent studies.
- Existing techniques typically assume data from distinct trials with similar characteristics.
- A gap exists in applying meta-analysis to parameters derived from individual hierarchical data structures.
Purpose of the Study:
- To demonstrate the applicability of meta-analytic techniques to parameters estimated from individual hierarchical data.
- To propose statistical methods that account for variances and covariances of these measures.
- To integrate these estimated parameters and variances within a general linear mixed model framework.
Main Methods:
- Application of meta-analytic statistical methods to individual hierarchical data.
- Incorporation of estimated parameters and their variances/covariances into a general linear mixed model.
- Utilizing SAS procedure MIXED for analysis, with provided example code.
Main Results:
- Successful application of meta-analytic techniques to hierarchical data parameters.
- Demonstration of integrating parameter variances within a mixed-effects model.
- Validation of the methodology using both a first-in-man study and simulated data.
Conclusions:
- Meta-analytical approaches can be effectively extended to analyze parameters from individual hierarchical data.
- The proposed statistical framework using general linear mixed models offers a robust method for such analyses.
- This broadened application of meta-analysis enhances the analysis of complex medical data structures.
Related Concept Videos
01:11Variability: Analysis
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
The range is a simple measure of variability, indicating the difference between the highest and...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:15Study Design in Statistics
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...